Bitnomial Launches INJ Futures, Paving the Way for an Injective ETF

Investors can now trade price movements of Injective (INJ) through a monthly futures contract launched by Bitnomial. The contract, settled in INJ, allows traders to speculate on the token’s price without holding it directly. The product is available to institutional investors now and will expand to retail users via Bitnomial’s Botanical platform in the coming weeks. This marks Injective’s first entry into the regulated US derivatives market. Under US SEC rules, the product could help build the six-month trading history required for an ETF approval. Canary Capital has already filed for an INJ ETF that includes a staking structure, and Cboe BZX has submitted a related proposed rule change to the SEC. Bitnomial, regulated by the CFTC, has previously expanded into altcoin derivatives with an Aptos (APT) futures product. The company’s INJ futures follow a broader trend of exchanges pushing into regulated US derivatives markets.